SCHEMBL30869854

SCHEMBL30869854

CC(C)(C)OC(=O)N1CCC2(CN(C(=O)OCc3ccccc3)CCO2)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MGLL Q99685 2/20 0.46
OPRD1 P41143 2/20 0.45
OPRK1 P41145 2/20 0.45
GPR119 Q8TDV5 1/20 0.44
SCD5 Q86SK9 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
HTT P42858 1/20 0.43
TACR1 P25103 1/20 0.43
RORC P51449 3/20 0.42
USP30 Q70CQ3 1/20 0.42
CHRM2 P08172 1/20 0.41
CHRM3 P20309 1/20 0.41
CYP2C19 P33261 1/20 0.41
ENPP2 Q13822 1/20 0.41
ATXN2 Q99700 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2821181 0.97 MEN1 (0.54) MEN1KMT2ANPSR1MGLLOPRD1
SCHEMBL30155294 0.87 MEN1 (0.46) MEN1KMT2ANPSR1MGLLGPR119
SCHEMBL31579558 0.86 YAP1 (0.48) MEN1KMT2ANPSR1MGLLGPR119
SCHEMBL15399354 0.85 MEN1 (0.59) MEN1KMT2ANPSR1MGLLOPRD1
SCHEMBL15958476 0.85 MEN1 (0.59) MEN1KMT2ANPSR1MGLLOPRD1
SCHEMBL15958479 0.85 MEN1 (0.59) MEN1KMT2ANPSR1MGLLOPRD1
SCHEMBL13115666 0.85 MGLL (0.57) MGLLOPRD1OPRK1CHRM2CHRM3
SCHEMBL17608925 0.84 CHRM2 (0.60) MGLLCHRM2CHRM3
SCHEMBL2629479 0.83 CYP11B2 (0.53) MEN1KMT2ANPSR1OPRD1OPRK1
SCHEMBL616090 0.83 SCD5 (0.52) MEN1KMT2ANPSR1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584275-A1 HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE Halda Therapeutics Opco, Inc. (US) 2025-07-16 EP disclosed
WO-2024054604-A1 HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE HALDA THERAPEUTICS OPCO, INC. (US) 2024-03-14 WO disclosed